Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Analysts

Stevanato Group S.p.A. (NYSE:STVN) has been assigned an average rating of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company.

Several equities analysts have recently weighed in on STVN shares. Wolfe Research started coverage on Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 target price on the stock. Bank of America boosted their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, December 13th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd.

Stevanato Group Trading Up 0.8 %

STVN stock opened at €23.87 ($24.86) on Tuesday. The firm has a market cap of $7.05 billion, a PE ratio of 50.79, a price-to-earnings-growth ratio of 10.49 and a beta of 0.56. The firm has a fifty day moving average price of €20.88 and a 200 day moving average price of €20.07. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. Stevanato Group has a fifty-two week low of €16.56 ($17.25) and a fifty-two week high of €34.73 ($36.18).

Stevanato Group (NYSE:STVN) last announced its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The business had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.16 earnings per share. Sell-side analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Natixis Advisors LLC increased its position in shares of Stevanato Group by 27.3% during the second quarter. Natixis Advisors LLC now owns 42,674 shares of the company’s stock worth $783,000 after acquiring an additional 9,146 shares during the period. TD Asset Management Inc increased its holdings in Stevanato Group by 324.2% during the 2nd quarter. TD Asset Management Inc now owns 108,853 shares of the company’s stock worth $1,996,000 after purchasing an additional 83,191 shares during the period. Thornburg Investment Management Inc. increased its holdings in Stevanato Group by 279.1% during the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after purchasing an additional 549,378 shares during the period. Oppenheimer Asset Management Inc. raised its position in Stevanato Group by 59.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock valued at $219,000 after purchasing an additional 4,441 shares in the last quarter. Finally, Blair William & Co. IL purchased a new stake in shares of Stevanato Group in the 2nd quarter worth $387,000.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.